Leo Pharma

Focus: Leo Pharma is a Denmark-based specialty pharmaceutical company focused on small-molecule therapies in immunology and endocrinology, with a concentrated portfolio anchored by the IL-13 antagonist ADBRY.

Immunology Endocrinology

Profile data last refreshed 12h ago · AI intelligence enriched 2w ago

Open Jobs

About Leo Pharma

AI assessmentNot Hiring

No open roles listed right now. Follow Leo Pharma to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

1 in 5yr

FINACEA

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

ADBRY

Atopic Dermatitis (IL-13 antagonist)

$32M

Peak

Cornerstone product representing 68% of company revenue; IL-13 mechanism addresses unmet need in moderate-to-severe AD.

Help build intelligence for Leo Pharma

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

no intervention is being made

Cancer

N/A

Clinical Trials (1)

NCT01559883Study on Thrombosis Therapy in German Cancer Patients

N/A

BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients wit

Atopic Dermatitis

N/A

Leukotriene B4

Skin Inflammation

N/A

Clinical Trials (1)

NCT03192280Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response

N/A

Diflucortolone valerate

Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development

N/A

Clinical Trials (1)

NCT03788863A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or in the Roof of the Mouth (Cleft Palate) in Newborns and the Use of Glucocorticoids by the Mother During Pregnancy: a Meta-analysis

N/A

Thrombin Generation Assay

Cancer

N/A

Clinical Trials (1)

NCT06386107Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis

N/A

Tinzaparin

Venous Thromboembolism

N/A

Clinical Trials (1)

NCT03099031Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)

N/A

Any topical drug treatment

Psoriasis Vulgaris

N/A

Clinical Trials (1)

NCT03402828Body PSOriasis: Long-term Relapse CONTROL

N/A

Ingenol Mebutate

Actinic Keratosis

N/A

Clinical Trials (1)

NCT03508856Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin

N/A

Azelaic Acid

Rosacea

N/A

Clinical Trials (1)

NCT03193372A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea

N/A

DLQI and PSO-TARGET QoL grid

Psoriasis

N/A

Clinical Trials (1)

NCT04765332Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients

N/A

Seocalcitol

Liver Neoplasms

N/A

Clinical Trials (1)

NCT00051532Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

N/A

Diflucortolone valerate

Dermatitis, Atopic

N/A

Clinical Trials (1)

NCT02627989An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids

N/A

Daivobet® Gel

Psoriasis Vulgaris

N/A

Clinical Trials (1)

NCT01707368Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation

N/A

calcipotriol/betamethasone dipropionate gel in Applicator

Plaque Psoriasis

N/A

Clinical Trials (1)

NCT02856542Real-life Evaluation of the Daivobet® Gel Applicator

N/A

Ingenol mebutate

Actinic Keratosis

N/A

Clinical Trials (1)

NCT04202445TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction

N/A

Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of

Skin Mycoses

N/A

Clinical Trials (1)

NCT00722189Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

N/A

Enstilar®

Plaque Psoriasis

N/A

Clinical Trials (1)

NCT02881346Efficacy and Tolerability of Enstilar® in Daily Practice

N/A

comprhensive spatial transcriptomic profile on lesional skin biopsies

Hand Eczema

N/A

Clinical Trials (1)

NCT06884163Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics

N/A

ingenol mebutate

Actinic Keratosis

N/A

Clinical Trials (1)

NCT02242747Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis

N/A

Ophthalmological Adverse Events of Tralokinumab in AD

Atopic Dermatitis

N/A

Clinical Trials (1)

NCT05682976Ophthalmological Adverse Events of Tralokinumab in AD

N/A

Calcipotriol/betamethasone dipropionate gel

Psoriasis Vulgaris

N/A

Clinical Trials (1)

NCT02636101Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study

N/A

Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomi

Multiple Myeloma

N/A

Clinical Trials (1)

NCT01268774Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.

N/A

Ingenol Mebutate

Actinic Keratosis

N/A

Clinical Trials (1)

NCT02090465Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks

N/A

Tinzaparin

Venous Thrombosis

N/A

Clinical Trials (1)

NCT00186745Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

N/A

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

Cancer-associated Thrombosis

N/A

Clinical Trials (1)

NCT03114618A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

N/A

Thrombosis biomarkers

Cancer

N/A

Clinical Trials (1)

NCT04301362Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients

N/A

Spanish Registry of Systemic Treatments in Psoriasis

Psoriasis

N/A

Ingenol mebutate 0.015 percent or 0.05 percent gel

Actinic Keratosis

N/A

Clinical Trials (1)

NCT02421471PMS to Evaluate the Safety and Efficacy of Picato® Gel

N/A

Villalta phone score > or = to 5

Post Thrombotic Syndrome

N/A

Clinical Trials (1)

NCT03054727Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )

N/A

Daivobet® Gel

Psoriasis Vulgaris

N/A

Clinical Trials (1)

NCT01320774Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

N/A

An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Be

Psoriasis Vulgaris

N/A

Clinical Trials (1)

NCT01982552An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life

N/A

Tralokinumab

Atopic Dermatitis

N/A

Clinical Trials (1)

NCT05938478Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

N/A

Ingenol mebutate

Actinic Keratosis

N/A

Clinical Trials (1)

NCT02362152The Real Life Topical Field Treatment of Actinic Keratosis Study

N/A

Xamiol® Gel

Scalp Psoriasis

N/A

Clinical Trials (1)

NCT01052467Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

N/A

not applicable, observational study

Atopic Dermatitis

N/A

Clinical Trials (1)

NCT05098821Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation

N/A

Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curat

Venous Thromboembolism

N/A

Clinical Trials (1)

NCT01803022Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer

N/A

tralokinumab

Atopic Dermatitis (Moderate-to-severe) Involving the Genital Region

N/A

Clinical Trials (1)

NCT07444801Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact

N/A

Enstilar® aerosol foam

Psoriasis Vulgaris

N/A

Clinical Trials (1)

NCT02935582PSOREAL - Managing PSOriasis in the REAL World

N/A

PsoBest - The German Psoriasis Registry

Psoriasis

N/A

A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of

Atopic Dermatitis

N/A

Clinical Trials (1)

NCT00475605A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis

N/A

Azelaic Acid Gel including: Finacea

Rosacea

N/A

Clinical Trials (1)

NCT02602470Preferences & Treatment Satisfaction Drivers in Rosacea Patients

N/A

Tinzaparin

Deep Vein Thrombosis

N/A

Clinical Trials (1)

NCT00967148Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer

N/A

tinzaparin

Inflammation

N/A

Clinical Trials (1)

NCT00135863MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis

N/A

No intervention

Psoriasis

N/A

Clinical Trials (1)

NCT03358914The PsoTeenQOL - Preliminary Reliability and Validity

N/A

Ingenol mebutate

Actinic Keratosis

N/A

Clinical Trials (1)

NCT02594436The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice

N/A

LEO 80185 gel

Psoriasis Vulgaris

Phase 1

Clinical Trials (1)

NCT02605057Dermatopharmacokinetic Trial of LEO 80185 Gel

Phase 1

pimecrolimus 10 mg/g cream

Atopic Dermatitis

Phase 1

Clinical Trials (1)

NCT02103725A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

Phase 1

Six different calcipotriol ointment formulations, and two currently marketed topical vitamin D analogues

Psoriasis Vulgaris

Phase 1

Clinical Trials (1)

NCT01105286A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis

Phase 1

Tralokinumab administered as 1 × X mL with Device A

Healthy

Phase 1

Clinical Trials (1)

NCT04674826A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects

Phase 1

delgocitinib

Atopic Dermatitis

Phase 1

Clinical Trials (1)

NCT03826901Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children

Phase 1

Leo Pharma

About Leo Pharma

Why Work Here

Key Products

Watch Out For

Products & Portfolio (6)

Key Products by Revenue

Other Products (3)

Pipeline & Clinical Trials

Open Jobs (0)